Completed OBSERVATIONAL NCT04789213

Mortality, Morbidity and Risk Factors of Liver Retransplantation

Comparison of Mortality, Morbidity and Risk Factors in Living- Donor and Deceased-Donor Liver Retransplantation

Sponsor: Memorial Bahçelievler Hospital

Conditions Liver Cirrhosis Liver Diseases Liver Failure Liver Transplant Failure Liver Transplant Rejection Liver Transplant; Complications Organ Transplant Failure or Rejection

Interventions Liver Transplantation

Updated 6 times since 2021 Last updated: Dec 2, 2021 Started: Mar 10, 2021 Primary completion: Apr 15, 2021 Completion: May 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Liver Cirrhosis and Liver Diseases, this trial is completed. The trial is conducted by Memorial Bahçelievler Hospital and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
May 2021 — Jan 2022 [monthly]

Recruiting

▶ Show 1 earlier version

Apr 2021 — May 2021 [monthly]

Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Memorial Bahçelievler Hospital

Data source: Memorial Bahçelievler Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)